Camurati-Engelmann disease: Failure of response to bisphosphonates: Report of two cases

Clinical Rheumatology

Volumn 24, Issue 4, 2005, Pages 398-401

  Castro, Glaucio R W ^a   Appenzeller, Simone ^a   Marques Neto, João Francisco ^a   Bértolo, Manoel B ^a   Samara, Adil M ^a   Coimbra, Ibsen ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bisphosphonates; Camurati Engelmann disease; Treatment

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; CLODRONIC ACID; CODEINE; COLECALCIFEROL; CORTICOSTEROID; DEFLAZACORT; MEDRONATE TECHNETIUM TC 99M; PARACETAMOL; PREDNISONE; RISEDRONIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE BIOPSY; BONE RADIOGRAPHY; BONE SCINTISCANNING; CAMURATI ENGELMANN SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAPHYSIS DYSPLASIA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HISTOPATHOLOGY; HUMAN; LIMB PAIN; OSTEOPENIA; OSTEOSCLEROSIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT FAILURE;

ADULT; BONE DENSITY; CAMURATI-ENGELMANN SYNDROME; DENSITOMETRY; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; RARE DISEASES; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 23344432093     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1056-7     Document Type: Article

References (13)

1. Sparkes RS, Graham CB (1972) Camurati-Engelmann disease: Genetic and clinical manifestations with a review of the literature. J Med Genet 9:73-85
2. Kinoshita A, Saito T, Tomita H et al (2000) Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19-20 10.1038/ 79128
3. Vanhoenacker FM, Janssens K, Van Hul W et al (2003) Camurati-Engelmann disease: Review of radioclinical features. Acta Radiol 44:430-434 10.1034/j.1600-0455.2003.00088.x
4. Applegate LJ, Applegate GR, Kemp SS (1991) MR of multiple cronical neuropathies in a patient with Camurati-Engelmann disease: Case report. Am J Neuroradiol 12:557-559
5. Minford AMB, Hardy GJ, Forsythe WI et al (1981) Engelmann's disease and the effect of corticosteroids: A case report. J Bone Joint Surg Br 63B:597-600
6. Greenspan A (1991) Sclerosing bone dysplasias - a target site approach. Skeletal Radiol 20:561-583 10.1007/BF00193816
7. Kumar B, Murphy WA, Whyte MP (1981) Progressive diaphyseal dysplasia (Engelmann disease): Scintigraphic-radiographic-clinical correlations. Radiology 140:87-92
8. Clybouw C, Desmyttere S, Bonduelle M, Piepsz A (1994) Camurati-Engelmann disease: Contribution of bone scintigraphy to genetic counseling. Genet Couns 5:195-198
9. Hernadez MV, Peris P, Guañabens N et al (1997) Biochemical markers of bone turnover in Camurati-Engelmann disease: A report of four cases in one family. Calcif Tissue Int 61:48-51 10.1007/s002239900293
10. Cherie-Lignière G, Santalena G, Parafioriti A (1999) Pamidronate in the treatment of progressive diaphyseal dysplasia (Camurati-Engelmann disease). Clin Exp Rheumatol 17:264
11. Rubin ZS, Ghiringhelli G, Mansur JL (1997) Evaluacion clinica, humoral y centellografica de un bisfosfonato como posible tratamiento em dos casos de displasias diafisarias: Las enfermadades de Ribbing y Camurati-Engelmann. Medicina 57 [Suppl 1]:56-60
12. Smith R, Walton RJ, Corner BD, Gordom IRS (1977) Clinical and biochemical studies in Engelmann's disease (progressive diaphyseal dysplasia). Q J Med 182:273-294
13. Inaoka T, Shuke N, Sato J et al (2001) Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease). Clin Nucl Med 26:680-682 10.1097/00003072-200108000-00003